Dr. John Glees MD FRCR DMRT
Consultant Radiotherapist and Clinical Oncologist
Dr John Glees is a Consultant Clinical Oncologist (specialising in radiation therapy and chemotherapy treatments for a whole variety of cancers). He is a Fellow of the Royal College of Radiologists U.K. (by Examination), M.D. with Honours and a Thesis on brain tumours. He also holds The Diploma of Medical Radiotherapy, London (DMRT). He has 40 years experience in the treatment of cancer.
Dr Glees specialises in the treatment of lung cancer, breast cancer, skin cancer, upper and lower G.I. cancers (pancreatic, rectal & anal cancer), gynaecological and urological cancers (kidney, bladder and prostate cancer).
He is also very experienced in the treatment of benign conditions (non Cancer) such as Dupuytren’s Disease (early claw hand), Peyronie’s Diseases, Psoriasis, Viral Warts, Keloids and Plantar Fasciitis and painful heel spurs using low dose radiotherapy.
Dr Glees has trained in England, Germany and United States. He gained his first radiotherapy experience in the United States working with Dr. Irwin Tepper. In 1971 he returned to the UK and was appointed to the Royal Marsden Hospital. Between 1981- October 2010 he held a joint Consultant post at St George’s University Hospital in London and The Royal Marsden Hospital and was an Honorary Senior Lecturer at the University of London. He has jointly written the protocols of skin cancer and bowel cancer at The Royal Marsden Hospital and St. George's Hospital and was involved in the radiation management of the Melanoma Unit both at St. George’s and the Marsden. He has published extensively and is an acclaimed conference speaker.
Dr Glees is now fully dedicated to his private practice at Lister Hospital in London and the Cancer Centre London, Parkside where he uses the latest drugs and radiotherapy techniques available. Dr Glees is currently Chairman of the RAD society, an association of UK and Ireland based consultant radiotherapists. The society has regular meetings worldwide to discuss the latest developments in the field of radiotherapy.